Wells Fargo analyst Stephen Baxter raised the firm’s price target on HCA Healthcare (HCA) to $452 from $431 and keeps an Equal Weight rating on the shares. For managed care organizations, the firm is most constructive on Medicare Advantage with uncertainty high for Medicaid/Exchanges. Wells sees a more difficult backdrop for hospitals in 2026 as post-COVID tailwinds wane and legislative risks near. Distributor debate remains revisions vs. multiples.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $503 from $486 at Bernstein
- HCA Healthcare price target lowered to $495 from $520 at Truist
- HCA Healthcare price target raised to $520 from $505 at Mizuho
- HCA Healthcare downgraded to Underweight from Equal Weight at Morgan Stanley
- Hospital stocks lower after Republicans propose Medicare funding cut